Return to homepagePandemic Pact

Mpox virus (MPV) asymptomatic transmission study during the outbreak in 2022

  • Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
  • Total publications:0 publications

Grant number: 142005748

Grant search

Key facts

  • Disease

    mpox

  • Start & end year

    2023
    2023

  • Known Financial Commitments (USD)

    $26,936.17

  • Funder

    State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)

  • Principal Investigator

    Abteilung Übertragbare Krankheiten Sekretariat der

  • Research Location

    Switzerland

  • Lead Research Institution

    University of Zurich

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Sexual and gender minorities

  • Occupations of Interest

    Unspecified

  • Mpox Research Priorities

    N/A

  • Mpox Research Sub Priorities

    N/A

Abstract

An outbreak of monkeypox virus (MPV) has been observed worldwide since May 2022. Unlike previous outbreaks, the chain of transmission appears to be continuing among people, especially among men who have sex with men (MSM). One hypothesis for this ongoing transmission is that, contrary to previous assumptions, asymptomatic carriers of the virus exist. These could be the driving force behind these transmission chains. The University of Zurich therefore wants to study asymptomatic MSM who are at risk of MPV infection. The study results can help improve the strategy for containing the virus: With the detection of asymptomatic carriers, testing recommendations can be adjusted.